Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration
Play • 11 min

Mary T. Bessesen, MD joins JAMA Network editors to discuss a cohort study that compares amputation and mortality rates among patients treated in the Veterans Health Administration for diabetic foot osteomyelitis with and without rifampin. Read the article here:

JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Clear search
Close search
Google apps
Main menu